Trials / Completed
CompletedNCT03725839
The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Fisher and Paykel Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This investigation is designed to evaluate the performance as well as the patients overall acceptance of the interface.
Detailed description
A minimum of 40 OSA participants who currently use CPAP will be recruited for the trial. Participant will be in the trial for three weeks- first week will be a collection of Positive Airway Pressure baseline data on participant's usual interface. The participant will then use the trial interface in-home for 2 weeks. There is also an option of a six month extension if the participant wish to continue on the trial interface.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | F&P Interface | F\&P Interface to be used for OSA therapy |
Timeline
- Start date
- 2018-11-05
- Primary completion
- 2019-11-30
- Completion
- 2019-11-30
- First posted
- 2018-10-31
- Last updated
- 2020-02-28
Locations
3 sites across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT03725839. Inclusion in this directory is not an endorsement.